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Cell-free translational strategies are needed to accelerate the repair of mineralised tissues, particularly large
bone defects, using minimally invasive approaches. Regenerative bone scaffolds should ideally mimic
aspects of the tissue's ECM over multiple length scales and enable surgical handling and fixation during
implantation in vivo. Leveraging the knowledge gained with bioactive self-assembling peptides (SAPs)
and SAP-enriched electrospun fibres, we presented a cell free approach for promoting mineralisation via
apatite deposition and crystal growth, in vitro, of SAP-enriched nonwoven scaffolds. The nonwoven
scaffold was made by electrospinning poly(3-caprolactone) (PCL) in the presence of either peptide P11-4
(Ac-QQRFEWEFEQQ-Am) or P11-8 (Ac QQRFOWOFEQQ-Am), in light of the polymer's fibre forming
capability and its hydrolytic degradability as well as the well-known apatite nucleating capability of SAPs.
The 11-residue family of peptides (P11-X) has the ability to self-assemble into b-sheet ordered structures
at the nano-scale and to generate hydrogels at the macroscopic scale, some of which are capable of
promoting biomineralisation due to their apatite-nucleating capability. Both variants of SAP-enriched
nonwoven used in this study were proven to be biocompatible with murine fibroblasts and supported
nucleation and growth of apatite minerals in simulated body fluid (SBF) in vitro. The fibrous nonwoven
provided a structurally robust scaffold, with the capability to control SAP release behaviour. Up to 75% of
P11-4 and 45% of P11-8 were retained in the fibres after 7 day incubation in aqueous solution at pH 7.4.
The encapsulation of SAP in a nonwoven system with apatite-forming as well as localised and long-term
SAP delivery capabilities is appealing as a potential means of achieving cost-effective bone repair therapy
for critical size defects.1. Introduction
Bone or tooth loss due to pathologies such as osteoporosis or
periodontal disease continue to represent major healthcare
challenges.1,2 Current therapeutic strategies include bone repair
or replacement by device implantation, allogeneic trans-
plantation or autologous bone gras. However, associated
clinical challenges, i.e.multiple number of surgeries and device
xation as well as increasing demand due to the aging pop-
ulation is motivating the need for alternative translational bone
repair strategies.
Mineralised tissues in nature are biological composites of
calcium phosphates minerals and so collagen matrices.3 Hard
tissues generally consist of a spectrum of collagen type I bres
and a mineral phase of substituted hydroxyapatite (HAP).4
Articial bone replacements or scaffolds for regeneration ofInnovation for Healthcare, University of
m
ity of Hudderseld, UK
, St James' University Hospital, Leeds, UK
tion (ESI) available. See DOI:
28342mineralised tissue have been realised in the form of composite
materials that mimic both the collagen matrix and the miner-
alised phase of the extracellular matrix (ECM).5 The most
frequently used biocomposite structures for bone regeneration
comprise a so biodegradable polymer scaffold, to provide
a similar structure and/or biological function as collagen, and
an inorganic phase, such as synthetic HAP, due to its biocom-
patibility, nontoxicity, and osteoinductive properties.6–8
An alternative approach involves mimicking the physiolog-
ical processes of nucleation and growth of apatite crystals in the
ECM of skeletal tissues, aiming to achieve the hierarchical
organisation and mechanical properties found in bone in vivo.9
Research has therefore been carried out to generate bioactive
scaffolds with the ability to promote nucleation and support
HAP crystal growth similar to that seen in ECM.10,11 Apatite
forming capability of polymer scaffolds can be evaluated by
incubating them in a near-physiologic conditions, e.g. in
simulated body uid (SBF) in vitro, which has an ion concen-
tration comparable to that of human blood plasma. Any
nucleated crystals can then be characterised.12,13
The 11-residue family (P11-X) of self-assembling peptides
(SAPs) when incubated in near-physiologic conditions,This journal is © The Royal Society of Chemistry 2020
Table 1 Sample nomenclature and formulation used in this study. All
samples were prepared from a HFIP solution of PCL (6% w/w)
Sample ID Sample specication
1 100% PCL
2 PCL/P11-4 ([P11-4]: 10 mg mL
1)
3 PCL/P11-4 ([P11-4]: 20 mg mL
1)
4 PCL/P11-4 ([P11-4]: 40 mg mL
1)
5 PCL/P11-8 ([P11-8]: 40 mg mL
1)
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View Article Onlinegenerates three-dimensional hydrogel scaffolds that mimic the
organic chemical composition of the ECM of hard tissues and
are capable of inducing apatite deposition in situ.14 P11-X SAPs
consist of hydro-gelating amino acidic sequences that assemble
into hydrogen bonded b-sheet tapes (a single-molecule thick)
above a critical concentration (C*),15 with higher order struc-
tures (ribbons, brils and bres) being realised if the concen-
tration is further increased.16 This class of peptides also
undergoes self-assembly when subjected to external stimuli
such as variation in pH17 and ionic strength,18 which can be
exploited in e.g. stimulus-triggered drug delivery. Among the P11
category of peptides, P11-4 and P11-8 exhibit an overall net
charge of 2 and +2, respectively, and have been demonstrated
to display low immunogenicity in vivo and no cytotoxic effects in
human and murine cells.16,19,20 They have promising properties
for biomedical applications and tissue regeneration in
glycosaminoglycan-depleted tissues including cartilage, in so
tissues and in bone.14,20,21–26
Most previous studies using P11-X peptides have focused on
the molecular design of self-assembled hydrogels, whereby
promising results have been shown with regard to cell growth
and hard tissue repair.14,16,20,24,27–29 Kirkham et al.14,23 evaluated
P11-4 in treating early dental caries (decay) wherein the peptide
was found to promote nucleation and growth of HAP in situ
within the lesions.
Moreover, P11-4 and P11-8 hydrogels were applied in vivo to
critical size defects in rabbit calvaria and bone regeneration was
observed over three months, with mineralised tissue ingrowth
observed to be greater in calvaria treated with negatively
charged P11-4- than positively charged P11-8-samples.25 In
another in vivo study, it was shown that P11-4-based hydrogel
accelerated healing in calvarial defects in rats.30 This was
attributed to the ability of P11-4 to act as a heterogeneous
nucleator in the assembled form through negatively charged
domains that attract calcium ions and form the nucleus for HAP
deposition.30
An important requirement for resorbable bone tissue scaf-
folds is to maintain a stable structure over time capable of
promoting regeneration via progressive apatite crystal deposi-
tion and crystal growth.31 Despite the biofunctionality of self-
assembled P11 peptide-based gels, they frequently suffer from
poor strength and lack of dimensional connement in situwhen
used in regenerative medicine applications. This canmake their
handling and surgical xation challenging in large load-bearing
tissue defects. The incorporation of SAPs within PCL electro-
spun bres can overcome these challenges while retaining the
scaffolds' bioactivity32–34 and we have previously demonstrated
that polymer-assisted peptide electrospinning successfully
enables the formation of molecularly-assembled peptide
nanobres in an electrospun nonwoven.35–37 P11-8-supple-
mented electrospun PCL webs were also found to be biocom-
patible with mouse broblasts.36,37
In this work, we investigated the apatite induction capability
of both P11-4- and P11-8-supplemented PCL nonwoven scaffolds
and characterised the peptide release behaviour, bre
morphology and wettability, as well as the cytotoxicity of both
variants. The nonwoven scaffolds were also studied in SBF toThis journal is © The Royal Society of Chemistry 2020explore their capacity to nucleate and grow HAP crystals.
Furthermore, we quantied the release behaviour of the SAPs
component of the nonwoven scaffolds when they were physi-
cally dispersed in aqueous media at different pHs, aiming to
evaluate the potential retention of peptides within any defect
site as this is an important factor to support the bone regen-
eration process.312. Materials and methods
2.1. Preparation of solutions and electrospinning
PCL (Mn: 80 000 g mol
1) and HFIP (purity $ 99.0%) were
purchased from Sigma Aldrich UK. Peptides P11-8 (CH3CO-Gln-
Gln-Arg-Phe-Orn-Trp-Orn-Phe-Glu-Gln-Gln-NH2) (Mw ¼ 1.565,
a peptide content of75%, and a HPLC purity of 96%) and P11-4
(CH3CO-Gln-Gln-Arg-Phe-Glu-Trp-Glu-Phe-Glu-Gln-Gln-NH2)
(Mw ¼ 1.595, a peptide content 94.9% and a HPLC purity of
95.0%) were purchased from CS Bio Co. USA. Electrospinning
solutions of 6% (w/w) PCL in HFIP with either 10, 20 or 40 mg
mL1 of P11-4 were prepared according to the method explained
previously.37 Additionally, a PCL solution supplemented with
40 mg mL1 P11-8 were prepared for biomineralisation studies.
All of the solutions were spun using a standard single spinneret
electrospinning setup and other processing parameters were
identical to those previously reported.37 Sample nomenclature
is dened in Table 1.2.2. Scanning electron microscopy (SEM & EDX)
Dry electrospun samples were sputter coated with platinum
with a thickness of 8 nm and imaged using a eld emission gun
scanning electron microscope (LEO1530 Gemini). The micro-
scope was also tted with an energy-dispersive X-ray spec-
trometer (EDX) of Oxford Instruments AztecEnergy to
investigate the chemical composition of the mineralised crys-
tals on the scaffolds aer biomineralisation assay.2.3. Surface wettability and direct cytotoxicity assay
The degree of hydrophilicity and biocompatibility of scaffold
samples 2–4 were assessed using goniometry (FTA 4000
Microdrop®) and a contact cytotoxicity assay usingmurine L929
cells respectively. Results were compared with previously pub-
lished data for samples 1 and 5 obtained using identical
methods.37RSC Adv., 2020, 10, 28332–28342 | 28333
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View Article Online2.4. Peptide release from PCL/peptide scaffold samples
Peptide-supplemented scaffold samples (3 replicates) with an
original peptide concentration of 40 mg mL1 (sample 4 and 5)
along with control sample 1 were incubated in water and
titrated to different pH values: 3.5, 7.5 and 10.5 at 25 C. The
purpose was to determine the kinetics of peptide disassembly
and release, enabling the stability of the peptides in the bres to
be evaluated under simulated biological conditions. The ratio of
bre to buffer solution was 1 mg in 3 mL (calculated based on
the critical concentration C* for self-assembly of the peptides16)
and the samples were incubated at 120 rpm in an orbital shaker
incubator (ES-20 model from Grant Bio) at 37 C. Aer 1 hour,
24 hours, 48 hours and 168 hours the samples were washed
three times in the same fresh solution of identical pH to remove
all remaining peptide residues and were dried in a desiccator.
Overall mass loss from the scaffolds was then determined
gravimetrically aer incubation, based on the dry state.2.5. Circular dichroism spectroscopy (CD)
To analyse the release of peptides from bres into solution, CD
analysis of the supernatant uid was conducted and spectra
were recorded using a Chirascan CD spectrometer with 1 mm
path-length cuvettes at 22 C. The data were acquired at a step
resolution of 1 nm and scan speed of 60 nm min1. A band-
width of 4.3 nm was used to obtain smoother spectra. Far-UV
spectra were recorded in the wavelength range 185 to 260 nm.
Each spectrum was the average of two scans and the spectrum
for the blank solvent was subtracted. The data then were con-
verted to mean residue ellipticity (deg cm2 dmol1) and tted
with a polynomial equation (R2 $ 0.95).2.6. Incubation of bres in simulated body uid (SBF)
The apatite-forming capability of scaffold samples containing
peptide (numbers 4 and 5) was evaluated in vitro in SBF based
on the international standard method of BS ISO 23317:2014
and compared with the control sample 1. The electrospun
PCL/P11-4 and PCL/P11-8 samples (3 replicates) were cut out (70
 10 mm  70  10 mm) and weighed with 40 mg of peptide
available in each sample, calculated based on the concentra-
tion and purity of each peptide in the spinning solution. SBF
was prepared in accordance with the standard method in ion-
exchanged and distilled water analytical grade chemicals lis-
ted in ESI Table 1.†38
The pH of the SBF solution was adjusted to 7.4  0.1 at 36.5
 0.2 C. Samples were incubated at 36.5 C in SBF with a ratio
of 0.5 mg mL1, as suggested by Poologasundarampillai et al.,39
at three time points of 1, 2 and 4 weeks, and then gently rinsed
with distilled water. Unwashed specimens were also retained to
determine the effect of washing. Finally, the samples were dried
in a desiccator at room temperature for 48 hours.Fig. 1 Schematic of potential application of electrospun SAP loaded
scaffolds; (A) dental cavity management where the defect can be filed
by a customised size and shape scaffold and it can then be fixed within
the defect by e.g. using a biodegradable glue. (B) Orthopaedic GBR
membranewhere the scaffold can be wrapped around an already filled
defect to guide the bone tissue regeneration and prevent soft tissue
intervention.2.7. X-ray diffraction crystallography (XRD)
XRD was selected for this study as it is a well-established non-
destructive technique for the identication of HAP and also to
conrm the EDX and SEM analysis. Samples were examined by28334 | RSC Adv., 2020, 10, 28332–28342XRD (PANalytical X'Pert MPD tted with X'Pert Highscore Plus
soware) to determine the molecular structure of crystalline
material formed on scaffolds during incubation in SBF.
Samples were placed as at sheets in the sample holder and
data collection was based on the 2q scan method using Cu Ka
radiation. Spectra were collected between 5 and 65 with a step
size of 0.05 and accelerating voltage of 45 kV.2.8. Statistical analysis
Statistical analysis was carried out in relation to the differences
in the Ca : P ratios aer incubation in SBF. A single factor
ANOVA test was carried out to compare the results of the three
time points (1, 2 and 4 weeks) and a t-test to determine any
effect of the washing process on the results of paired data
(washed and unwashed).3. Results and discussion
Electrospun scaffolds of PCL with varying concentration of P11-4
were successfully produced and their bre morphology, water
contact angle and cytotoxic response were compared with our
previously reported PCL/P11-8 scaffolds.37 Moreover, the peptide
release kinetics and apatite-nucleation/crystal growth capability
of both P11-4- and P11-8-supplemented scaffolds were analysed
to elucidate their potential to achieve a long-term therapeutic
delivery of SAPs to repair critical size bone defects.
The present work investigates the mineralisation capability
in vitro of the P11-4 and P11-8-loaded PCL bres, as a rst step to
assess their applicability in guided bone regeneration therapy.
Building on the bioactivity of the above-mentioned
peptides,14,20,21,23–25,30 the materials developed in this study
could therefore nd applications in dental tissue repair or asThis journal is © The Royal Society of Chemistry 2020
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View Article Onlinea barrier membrane to stimulate the repair of critical size bone
defects (CSBDs) (schematic shown in Fig. 1). In the rst
instance, an advanced caries lesions with the total breakdown
of the enamel, known as ‘cavity’ can be lled with a customised
membrane scaffold, benetting from surgical handling capa-
bility, excellent biocompatibility and easy customisation of the
material in terms of shape and size at the chair side for different
shapes of cavities. The scaffold material then can be xed using
a biodegradable tissue glue e.g. cyanoacrylate glue within the
cavity40 and promote repair by providing a biomimetic scaffold
capable of HAP nucleation, and mineralised tissue growth. In
the second proposed application, the CSBD is lled with an
autogra or a synthetic bone gra that supports the weight
strain in case of a weight-bearing defect, and then the defect siteFig. 2 (A–D) SEMmicrographs of PCL and P11-4-supplemented nonwove
of 10, 20 and 40 mg mL1 respectively. (E) Dynamic water contact angle
concentration of 10 (-) and 20 mg mL1 (C) and (F) light microsco
concentration of 40 mg mL1.
This journal is © The Royal Society of Chemistry 2020can be wrapped with the membrane for guided bone regener-
ation (GBR) and to direct the growth of new bone. The
membrane architecture, porosity and thickness can be cus-
tomised to act as barrier to prevent so tissue growth and
invasion from outside and the inner side can promote miner-
alised tissue ingrowth due to SAPs availability at the surface.
The membrane can then be xed using degradable screws for
the orthopaedic xation,41 and it can also be designed to be
degradable within a suitable prole.3.1. Fibre morphology and wettability
Fig. 2A–D are micrographs of nonwoven samples 1–4 electro-
spun with varying concentrations of P11-4 (0–40 mg mL
1). Thens: (A) sample 1; PCL, (B–D) sample 2–4; PCL with P11-4 concentration
on electrospun scaffolds for 15 s of samples 2, and 3, PCL with P11-4
py images of L929 cells in contact with sample 4, PCL with P11-4
RSC Adv., 2020, 10, 28332–28342 | 28335
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View Article Onlineaddition of P11-4 into pure PCL spinning solution results in
a bimodal superimposed nanobrous network similar to that
previously observed in the spinning of P11-8-supplemented
electrospinning PCL solutions.37
As observed previously with P11-8-supplemented PCL
bres,37 relatively small contact angle values of 58 1 and 70
1 were observed in peptide-enriched nonwovens when the
concentration of peptide increased from 10 to 20 mg mL1,
sample 2 and 3 respectively (ESI Fig. 1A and B†). In contrast,
a contact angle of 130  0.5 has been observed for 100% PCL
electrospun bre webs,37 providing supporting evidence of the
peptide-induced increase in scaffold wettability in deionised
water. Fig. 2E illustrates the dynamic contact angles of deion-
ised water on samples 2 and 3 where wetting progressively
increased as a result of higher peptide content. At the higher
P11-4 concentration of 20 mg mL
1 (sample 3), the rate of
wetting was so rapid that aer 3 s complete penetration of the
droplet occurred. This was in contrast to the hydrophobic
response of the 100% PCL sample, where the contact angle was
invariant over the 15 s test period.37 At 40 mg mL1 peptide
concentration (sample 4), the rate of droplet penetration was so
rapid that a contact angle could not be determined.
In line with the aforementioned contact angle observations,
Fig. 2F conrms that the L929murine broblasts proliferated in
direct contact with P11-4-enriched bres (sample 4) with no
evidence of cytotoxicity. The L929 cells were selected to conform
with the ISO standards related to the cytotoxicity evaluation of
medical devices (EN DIN ISO standard 10993-5). These ndings
are comparable to those observed when P11 peptides were
cultured in DMEM.37 The quantitative results from the direct
cytotoxicity assay (ESI Fig. 1C†) also revealed that the number of
living cells in the PCL/P11-4 (sample 4) and PCL/P11-8 (sample 5)
were comparable to that of the PCL negative control sample (p$
0.05) and the DMEM control. This is to be expected due to the
non-cytotoxic nature of PCL and self-assembled peptides during
the time of cell culture period. The mean optical density (OD) of
the samples was used to calculate the percentage of cell viability
based on the equation reported by Park et al.42 (ESI Table 2†).
PCL/P11-4 (sample 4) and PCL/P11-8 (sample 5) showed at least
84% and 77% cell viability, respectively, compared to the
DMEM control, and up to 100% and 92% cell viability compared
to the PCL control.3.2. Peptide release kinetics from PCL bres
Maintainence of a stable structure is an important requirement
for bone tissue scaffolds, while newly regenerated tissue is
formed and bone mineralisation takes place.30 In an in vivo
study by Burke et al., P11-4 and P11-8 hydrogels injected into full
thickness calvarial defects in rabbits supported bone repair
which was complete in some cases and incomplete in others.21
Evidence of full peptide hydrogel diffusion (i.e. complete
depletion) was reported within some of the defects by day 7,
which may have contributed to the incomplete defect repair. In
the current study, the physical incorporation rather than cova-
lent immobilisation of the peptides within a degradable PCL
nonwoven has the potential to modulate the rate of peptide28336 | RSC Adv., 2020, 10, 28332–28342diffusion and therefore further support the bone regeneration
process in vivo.
Moreover, it is paramount to consider the effect of pH on the
stability of bone scaffold and peptide release kinetics. The SAPs
studied herein are known to be pH-sensitive, such that they self-
assemble into brils in water depending on the pH and peptide
concentration in solution. In principle, all of the trans-
formations from monomeric random coil to self-assembled
brils are reversible16,43 and as such, all incubation experi-
ments were carried out in aqueous media at acidic, neutral and
basic pHs.
Peptide release from the bres was determined gravimetri-
cally before and aer incubation in water. Fig. 3A shows that the
overall mass loss of peptide containing bres increased over
a period of 168 hours (7 days). However, the mass of PCL control
bres did not change over the same period of time regardless of
the pH of the solutions. Therefore, the overall mass loss in the
PCL/peptides bres is likely to be due to the release of peptides
from the bres into solution.
As expected, the highest mass loss in P11-4-supplemented
nonwoven scaffolds took place aer 168 hours of incubation at
pH 10.5 (up to 9.3%), and for PCL/P11-8, aer 168 hours of
incubation at pH 3.5 (up to 14.5%). Note that these are the least
favourable pH values for each of the two peptides respectively,
i.e. the pH values at which each of the peptides are expected to
transform from self-assembled b-sheet form (brils and bres)
to monomers (non-Newtonian uid).43 Based on the peptide
purities and solution concentrations of 40 mg mL1, the initial
weights of peptide in the PCL/P11-4 and PCL/P11-8 scaffolds
prior to incubation were 28% (w/w) and 24% (w/w) respectively.
Therefore, in the PCL/P11-4 bres, only 33% of the original P11-4
content was presumed lost over 168 hours, and for the PCL/P11-
8 samples it reached 60%, in the least favourable conditions.
The opposite net charge of P11-8 (+2) and P11-4 (2) was also
found to play a key role on the scaffold's release capability; P11-
8-supplemented nonwoven samples displayed the highest
apparent release of peptide in acidic conditions, whereby the
168 hours cumulative release was decreased at both neutral and
basic pH; whilst the opposite trend was observed with P11-4-
supplemented nonwoven samples. Aforementioned trends in
release kinetics putatively reect the effect of peptide electro-
static charge and respective electrostatic interactions with
solution ions at the pHs investigated.
At a pH of 7.5, which is closest to biological conditions (pH
7.4), 75% of the P11-4 and 45% of the P11-8 apparently remained
within the electrospun bres aer 168 hours. This is noteworthy
given how quickly the same peptides were reported to diffuse
from a treatment site when delivered in the form of a hydrogel.21
The bres were also analysed microscopically to monitor
morphological changes, e.g. bre size, which can be expected to
happen aer diffusion of the SAPs to the solutions. ESI Fig. 2†
shows SEM micrographs of 100% PCL, P11-4 and P11-8-supple-
mented nonwovens (sample 1, 4 and 5 respectively), incubated
for up to 168 hours at the lowest and highest levels of pH of 3.5
and 10.5 respectively. No marked differences in general nano-
brous architecture were observed for the P11-4 or P11-8-sup-
plemented nonwovens (and control PCL) aer 168 hours ofThis journal is © The Royal Society of Chemistry 2020
Fig. 3 (A) Overall mass loss of peptide from sample 4 and 5 (PCL with P11-4 and P11-8 concentration of 40 mg mL
1 respectively) in aqueous
solution at different pH (A). (B and C) CD spectra of supernatant of fibrous samples 4 and 5 (PCL with P11-4 and P11-8 concentration of 40 mg
mL1 respectively) dissolved in water for 1, 24, 48 and 168 hours at pH 3.5 and pH 10.5 respectively.
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View Article Onlineincubation other than a attened bre morphology and a minor
swelling, most probably due to water absorption. Consequently,
the observed difference in the level of retained P11-8 and P11-4
peptides is likely to reect the effect of peptide-induced elec-
trostatic interactions with solution ions, as well as the different
bre dimensions in the two brous scaffolds, which will inu-
ence the length of the internal diffusion pathways. A larger
proportion of the bres in the P11-8 sample were below
a diameter of 100 nm promoting rapid peptide diffusion,
compared to samples containing P11-4 peptide.37
To conrm release of peptides into the solution, the super-
natant uid of 100% PCL, P11-4 and P11-8-supplemented scaf-
folds which were incubated at the lowest and highest values of
pH; 3.5 and 10.5 respectively, for 24 hours and 168 hours, were
analysed. CD analysis was then conducted and the results are
shown in Fig. 3B and C, with the spectra of the associated blank
solution subtracted. All the CD spectra for the P11-4 and P11-8
supernatants exhibited a negative minimum band at 195–
200 nm and a slightly positive band at around 220 nm, which is
consistent with disassembly of the peptides into a random coil
conformation in solution.16,44 This explanation is supported by
the lack of a negative band at 218 nm, and a strong positive
maximum at lower wavelengths (198 nm), which would be
characteristic of b-sheet conformation.15,45 Comparing these
results with those of the PCL bre supernatant, which exhibited
no peaks in the far-UV spectral region (190–250 nm), it can beThis journal is © The Royal Society of Chemistry 2020conrmed that peptides are disassembled into solution over
time. Moreover, the peak intensities in the CD spectra support
the results of the mass loss experiments, in which the highest
mass losses obtained for the P11-4 and P11-8-supplemented
nonwovens aer 168 hours of degradation were observed at pH
10.5 and pH 3.5 respectively.3.3. Apatite-nucleation ability of bres following incubation
in SBF
Representative SEMmicrographs of scaffold samples incubated
in SBF for one, two and four weeks' duration are given in Fig. 4.
Aer one week's incubation, no apatite crystals could be
detected on P11-8-supplemented scaffolds (sample 5) (Fig. 4J)
and only a small amount of crystals was observed in P11-4-
supplemented scaffold (sample 4) (Fig. 4D and G). However,
increasing the incubation times in SBF to 2 weeks and 4 weeks
(Fig. 4E, F, H, I, K and L) led to substantial crystal nucleation
and growth, both on the surface of, and within the pore struc-
ture of the peptide loaded scaffolds.
No evidence of apatite crystal formation was observed on the
PCL control samples containing no peptides, even aer the
longest incubation time of four weeks (Fig. 4C). Apatite crystals
formed on the peptide-loaded bre surfaces and within the
proximal pore network exhibited a globular, cauliower-like
shape, resembling clusters of HAP crystals.39 It may beRSC Adv., 2020, 10, 28332–28342 | 28337
Fig. 4 SEMmicrographs of electrospun scaffolds following incubation in SBF: (A–C) sample 1; PCL after one, two and four weeks. (D–F) Sample
4, PCL with P11-4 concentration of 40mgmL
1 after one week, two weeks and four weeks. (G–I) Lowmagnification SEMmicrographs of sample
4, after one, two and four weeks incubation showing the distribution of crystals formed all over the fibres. (J–L) Sample 5, PCL with P11-8
concentration of 40 mg mL1 after one, two and four weeks.
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View Article Onlineassumed that a primary layer of calcium phosphate is formed
over the surface of the bres in the scaffold, over which further
growth of spheroidal clusters proceeds.
Low magnication SEM micrographs (1000–3000) of P11-4-
supplemented samples incubated in SBF for one, two and four
weeks, revealed a distribution of mineralised crystals all over
the brous structure, Fig. 4G–I. The frequency of crystal28338 | RSC Adv., 2020, 10, 28332–28342formation within the brous structure increased with incuba-
tion time, and the scaffold's brous structure provided a sup-
porting matrix for apatite crystals, promoting their attachment
and growth.
3.3.1. Atomic ratio of Ca : P via energy-dispersive X-ray
(EDX) analysis. The increase in amount of crystal deposits on
the SAP-supplemented scaffolds with incubation time was alsoThis journal is © The Royal Society of Chemistry 2020
Table 2 Mean Ca : P ratio of the electrospun scaffolds incubated in SBF for up to 4 weeks based on EDX analysis (concentration of P11-4 and P11-
8 is the solution: 40 mg mL1)
Sample
Incubation time
Ca : P (1 week) Ca : P (2 weeks) Ca : P (4 weeks)
Washed Unwashed Washed Unwashed Washed Unwashed
PCL 0 0 0 0 0 0
PCL supplemented with P11-4 1.68 (SD ¼ 0.21) 1.77 (SD ¼ 0.03) 1.72 (SD ¼ 0.09) 1.64 (SD ¼ 0.42) 1.76 (SD ¼ 0.30) 1.82 (SD ¼ 0.27)
PCL supplemented with P11-8 0.01 (SD ¼ 1.3) 0.31 (SD ¼ 1.8) 0.50 (SD ¼ 0.7) 1.50 (SD ¼ 0.1) 0.21 (SD ¼ 0.33) 1.65 (SD ¼ 0.39)
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View Article Onlineconrmed by elemental analysis (EDX). ESI Table 3 and Fig. 3†
report representative data and the EDX pattern for sample 4
incubated in SBF for 2 weeks and a calcium to phosphorus ratio
of 1.72 is revealed, which is broadly consistent with apatite
formation at the surface.46
All of the incubated PCL and SAPs-supplemented nonwovens
showed peaks corresponding to C and O, together with minor
peaks for Na, Cl, K and Mg, attributable to ion precipitation.
However, samples comprising PCL/peptides also showed char-
acteristic peaks for phosphorus (2.01 eV) and calcium (3.69 eV)
suggesting the presence of apatite. Themean Ca : Pmolar ratios
for all samples before and aer washing are summarised in
Table 2 based on EDX analysis of random positions on indi-
vidual mineral particles (n ¼ 3 per sample).
In the PCL control sample, no mineral deposition was
observed, as conrmed by visual observations in the SEM study.
The Ca : P molar ratios in the P11-4-supplemented scaffolds
(sample 4) from week 1 of incubation was close to 1.67, which is
indicative of HAP.39,46 The Ca : P molar ratio for these samples
were comparable at different time points and no signicant
difference was observed (P > 0.05). These data also suggest that
the washing process did not markedly affect the Ca–P mineral
deposition on P11-4-supplemented samples (P > 0.05).
In the P11-8-supplemented scaffolds (sample 5), the Ca : P
ratio of SBF-incubated samples was found to be directly relatedFig. 5 X-ray diffraction patterns of electrospun scaffolds before and aft
samples): (A) sample 4; PCL with P11-4 concentration of 40 mg mL
1 an
This journal is © The Royal Society of Chemistry 2020to the incubation time in SBF. A Ca : P ratio of 1.65 was
measured in retrieved samples only aer four weeks, whilst
decreased and highly variable values of Ca : P ratio were
observed at earlier time points, suggesting a lower and uncon-
trollable mineralisation capability of P11-8- with respect to P11-4-
enriched bres. Furthermore, the average Ca : P ratios in
samples composed of P11-8 appeared to be decreased in
retrieved samples following washing in water at all the time
points, whereby statistical analysis of washed and unwashed
results at week 4 showed signicant difference in Ca : P ratios (P
< 0.05). This suggests the deposition and precipitation of
calcium phosphate species on the bre surface in addition to
the mineralisation of calcium phosphate crystals.
The difference in the above results may be attributable to
differences in the morphology of the P11-4-supplemented scaf-
folds compared to those of P11-8. In the latter case, a biphasic
structure exists, with a larger number of peptide-enriched
nanobers that bridge the pores between larger submicron
bres.37 Owing to their nanober dimensions and large surface
area, a shorter diffusion pathway for the peptide component at
the bre surfaces may be expected, and therefore a more rapid
dissolution. By contrast, the P11-4-supplemented scaffolds
showed greater control over mineralisation. This could be due
to either the effect of the negatively-charged surface, promoting
a template for stabilisation of calcium ions; or the presence ofer two and four weeks incubation in SBF (both washed and unwashed
d (B) sample 5; PCL with P11-8 concentration of 40 mg mL
1.
RSC Adv., 2020, 10, 28332–28342 | 28339
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View Article Onlinefewer nanobers, suggesting that the peptide is mainly incor-
porated within larger diameter bres, Fig. 2. Any minerals
associated with the nucleating site of the peptide will therefore
also be attached to a more stable substructure, and less likely to
be removed by washing. Moreover, the supercial washing out
of peptide at the surface of these bres will be replenished and
this will allow for further exposure of active groups towards the
bres' surface, thereby creating an area of high crystal growth
support.
The spheroidal morphology of the calcium phosphate crys-
tals on the SAPs enriched bres may arise from the nature of the
nucleating site in the peptides and their affinity for mineral
ions. As both peptides have a net charge (2 or +2), it is sug-
gested that they drive mineralisation through either cation or
anions ion attraction (calcium or phosphate) thereby providing
a site for crystal growth.47 Moreover, the molecular organisa-
tional structure of the peptides into brils and presentation of
charge domains at the brillar surface will inuence the capa-
bility of assembled peptides to nucleate and support crystal
growth in vitro.
3.3.2. X-ray diffraction analysis. X-ray diffraction patterns
of electrospun 100% PCL, P11-4 and P11-8-supplemented
samples aer two and four weeks are presented in Fig. 5. The
data are normalised and two distinct diffraction peaks were
observed in all samples at 2q¼ 21.5 and 2q¼ 23.8, which were
indexed to the crystalline structure of PCL.48,49 In the PCL
control (sample 1) patterns (ESI Fig. 4†), no additional peaks
were observed aer incubation in SBF. By contrast, incubation
of PCL/peptide samples in SBF (Fig. 5) all led to additional X-ray
diffraction peaks.
The peak at 2q ¼ 31.8 and an isolated peak at 2q ¼ 46.6, in
P11-4 and P11-8-supplemented nonwovens aer incubation is
indicative of the presence of HAP.50 The patterns relating to HAP
in the PCL/peptides bres were sharper in the unwashed
samples, indicating that the crystallinity or size of crystals
decreased aer the washing process. However, the XRD patterns
of both the mineralised PCL/peptide samples aer two weeks
were very similar to those obtained aer four weeks, which may
indicate that there was no substantial increase in nucleation or
growth of minerals aer two weeks.
4. Conclusion
The electrospun PCL scaffolds supplemented with P11-4 re-
ported in this study revealed high cellular tolerability when
L929 cells were seeded on the bres, whereby an averaged cell
viability of 84% and 100% was measured with respect to the
DMEM and PCL control, respectively. It is thought that the
incorporation of P11-4 and P11-8 into PCL scaffold nonwovens
can effectively prevent their rapid dissolution in near-
physiologic conditions. At least 40% of the P11-8 peptide and
65% of the P11-4 peptide remains within electrospun scaffolds
aer 7 days of incubation, even when pH conditions promote
transformation of the self-assembled peptide into their
respective monomeric state. At conditions close to biological
pH, at least 75% of P11-4 and 45% of P11-8 peptides apparently
remain in the scaffolds aer 7 days of incubation. PCL28340 | RSC Adv., 2020, 10, 28332–28342electrospun scaffolds containing P11 peptides therefore have
potential to modulate long-term therapeutic delivery to a bone
defect site.
PCL/peptides scaffolds were also shown to promote apatite
nucleation and subsequent growth of calcium phosphate crys-
tals in vitro, compared with PCL only bres. Apatite species
nucleated on PCL/P11-4 and PCL/P11-8 scaffolds are character-
istic of HAP aer only one and four weeks respectively. It was
found that P11-4 loaded scaffolds showed better control over
mineralisation even at decreased time periods, whilst HAP
mineralisation was not observed on P11-8 loaded scaffolds
earlier than four weeks. These ndings are in line with in vivo
reports on the bone regeneration capability of both peptides,
suggesting that both SAP-enriched bre nonwovens could serve
as regenerative scaffolds.20 Following the promising in vitro data
reported herein, it is clear that in vivo studies would be neces-
sary to ascertain the feasibility of developing a brous device to
full the potential target applications proposed in this report.
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